Cantor Fitzgerald Initiates Coverage On ArriVent BioPharma with Overweight Rating

Benzinga · 2d ago
Cantor Fitzgerald analyst Li Watsek initiates coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Overweight rating.